Invasive prenatal diagnostic techniques

If a risk of chromosome disease in fetus is hgher than populational (women aged above 35, child birth with a chromosome disease or presence of biochemical markers of chromosome disease– typical changes of the levels alpha – fetoprotein and chorionic gonadotropin), prenatal investigation of the fetal karyotype (chromosomal analysis) is recommended. For chromosamal analysis of the fetus fetal cells are required.

Invasive prenatal testing is used to identify fetus chromosome abnormalities (Down’s syndrome, Edwards’ syndrome, etc). Thus karyotyping of cells of chorion/placenta/amniocytes or blood lymphocytes sampling is provided. 

Karyotype analysis is a standard method available in our clinic for identifying numerical and structural chromosomal aberrations

Computer-aided analysis of the karyotype of a fetus with a Down syndrome, performed in our clinic

Fig.1 Computer-aided analysis of the karyotype of a fetus with a Down syndrome, performed in our clinic

Schematic of chromosome structure using the G-staining method in compliance with the international classification

Fig.2 Schematic of chromosome structure using the G-staining method in compliance with the international classification

The chromosome, chorion and placenta fibre cells analyses contribute significantly to the identification of chromosomal anomalies, such aberrations are revealed in 98.6% which helps to take the timely measures.

The up-to-date techniques allowed finding out that many severe congenital abnormalities are caused by numerical and structural chromosomal aberrations. Down syndrome is one of the most common and well-known chromosome abnormalities, being a severe congenital pathology with mental retardation, immunity disorders and heart activity disorders, etc. It occurs because of the presence of an extra 21st chromosome in the karyotype.

Invasive prenatal testing for fetus chromosome abnormalities is recommended in the following cases:

  1. For pregnant woman aged above 35 years old (e.g. Down’s syndrome generally occurs for 1 in 700 of newborns, but for 1 in 30 of children born by women aged above 35, this is true for other chromosome abnormalities as well);
  2. Down’s syndrome, other chromosome diseases, or multiple congenital abnormalities in history of a previous child (children);
  3. Ultrasonic markers of fetus chromosome abnormalities;
  4. Balanced chromosomal rearrangement in either parent;
  5. Realtive indication is a result of biochemical screening (alpha – fetoprotein and chorionic gonadotropin) indicating a high risk of Down syndrome.

Invasive methods alow to get a sample of fetal cells, or cells from provisional organs (chorionic villus sampling, placenta) for chromosomal analysis. This procedures is performed through transabdominal biopsy under ultrasound control. Techniques differ depending on pregnancy term.

Invasive methods performed in our clinic include:

  • Chorion biopsy is a procedure for taking a small piece of placental tissue (chorionic villi) (in 10-14 weeks);
  • Placenta biopsy is a procedure for taking a small piece of placenta cells (in 14-20 weeks);
  • Amniocentesis is a puncture of the fetal bladder for taking some amniotic fluid (in 15-18 weeks);
  • Cordocentesis is a procedure for obtaining blood cells from the umbilical cord (umbilical blood sampling) (after 20 weeks);

In rare cases a fetal tissues biopsy can be performed.

The risk of pregnancy complications (spontaneous termination of a pregnancy or a fetal death) after chorion biopsy and placenta biopsy  is 1% which is typical rate for the first trimester; for amniocentesis this rate is even lower - about 0.2%; for cerdocentesis it increases up to 3.3%.

Invasive prenatal techniques are available for the majority of monogenic diseases. All invasive testing techniques are used for this purpose. However, unlike the cytogenetic prenatal diagnostics including the karyotype study, the gene sequences or areas are examined. 

In case of monogenic diseases we provide all the invasive techniques for assesment of fetal cells. The samples are sent to professional laboratories specializing in particular molecular diagnostic techniques.

Nowadays in Russia the following testing for monogenic disorders is available:

  1. Adrenogenital syndrome
  2. Albinism type OCA 1
  3. Friedreich\'s ataxia
  4. Achondroplasia
  5. Wilson’s disease
  6. Willebrand’s disease
  7. Lesch-Nyhan syndrome
  8. Norry’s disease
  9. Unterricht-Lunborg’s disease
  10. Hunter’s disease
  11. Congenital arachnodactylia
  12. Congenital myodystrophy, type Fukuyama
  13. b- thalassemia
  14. Haemophilia A and B
  15. Hypophyseal nanosomia
  16. deficiency of acyl-CoA dehydrogenase of fatty acids with a medium chain length
  17. deficiency of alfa-1-antitrypsin
  18. Dushenn-Bekker myodystrophy
  19. Emery-Dreiyfus myodystrophy
  20. myotonic myodystrophy
  21. Tompson-Bekker myotonia
  22. Cystic fibrosis
  23. Sharko-Mary-Tut 1st type atrophy
  24. sensorineural hearing loss
  25. oculopharyngeal myodystrophy
  26. pseudoachondroplastic dysplasia
  27. recessive polycystic renal disease
  28. familial hypercholesteremia
  29. Alport\'s syndrome
  30. Acrosphenosyndactylia
  31. Coffin-Lowry’s syndrome
  32. Louis-Bar syndrome
  33. Martin-Bel’s syndrome
  34. Marfan’s syndrome
  35. Miller-Dicker syndrome
  36. Nijmegen syndrome
  37. Smitt-Lemly-Opitz syndrome
  38. Feminizing testes syndrome
  39. Holt-Omar’s syndrome
  40. Ehlers-Danlos syndrome (classical type)
  41. Spastic paraplegia
  42. Spinal and bulbar Kennedy’s amyotrophy
  43. Spinal Hoffmann’s, Kugelberg-Welander’s amyotrophy
  44. Felling’s disease
  45. Huntington\'s chorea
  46. Anhydrotic ectodermal dysplasia
  47. X-linked agammaglobulinemia
  48. X-linked lymphoproliferative disorder (Duncan’s disease)

Invasive prenatal diagnostics is applied for sex determination and determination of the paternity during the early pregnancy.

Contact us now! Get a free consultation!

  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • We ask you provide your full Date of Birth for more exact medical advice
  • This field is for validation purposes and should be left unchanged.
Dr. Olga's Patients' Gathering in Stockholm

Dr. Olga's Patients' Gathering in Stockholm

August 2017

Dr. Alena Egorova with baby Alice born a year ago with help of ICSI. Her dear Mom Anna (@eggdonationblog) is our great Egg Donation Team Leader since 2011, our renowned egg donor 2008-2010. Anna is good to talk to since she has been through both: being an egg donor and ICSI patient.

Dr. Olga's Patients' Gathering in Oslo

Dr. Olga's Patients' Gathering in Oslo

September 2017

Success Stories

After 7 unsuccessful embryo transfers in a local clinic, in April Andreas and Hanna have got their sweet baby boy after their second embryo transfer in O.L.G.A. Clinic. "Dear Dr. Nina, You were our doctor during IVF at O.L.G.A. clinic and I just wanted to let you know that our baby boy is here now!! You made the impossible possible!!! And we are forever grateful to the bottom of our hearts!!!" - Hanna and Andreas

Read more
Story of dear patient Nicole

"Frieda is such a cheerful baby. She wakes up and develops every day and the sense of my life is to see her growing, to support her and to love her unconditionally.", Nicole

Read more

Read more

We are so happy to share with you the story of our dear patients Liza and Niklas who have got their long-awaited daughter Mira at the age of 43 with the help of IVF with their own eggs and PGT-A in O.L.G.A. Clinic.

Read more

Watch video about our Team!

Media & Press

Read more, 17 Nov 2018 18:11. Text: Lars-Olof Strömberg. Photo: Jens Christian

Read more

BILLED-BLADET, Feb 2021. Text: Helle Skram De Fries SE OG HØR, Feb 2021. Text: Nikolaj Bonde, Niko@Sh.Dk

Read more
Join Our Webinars. Find out more!